<p>HepG2 control (A) and HepG2-NS5A (B) cell lines were cultured for 48 h with thapsigargin at 0, 1×10<sup>−4</sup>, 1×10<sup>−3</sup>, 1×10<sup>−2</sup>, 1×10<sup>−1</sup>, and 1 µM. Cells were washed and stained with crystal violet. (C), (D) HCV NS5A protects hepatocytes from thapsigargin-induced apoptosis. HepG2 control and HepG2-NS5A cells were cultured for 24 h with thapsigargin at 0, 1×10<sup>−1</sup>, and 1 µM. Apoptosis was evaluated using the APOPercentage Apoptosis Assay. Purple-red stained cells were identified as apoptotic cells by light microscopy. The number of purple-red cells/300 cells was counted. Data are expressed as mean ± standard deviation. *<i>P<0.05.</i></p
AbstractThe mechanisms of hepatocyte death and the events that lead to a high rate of chronic liver ...
AbstractHepatitis C virus (HCV) is a major etiologic agent of chronic hepatitis worldwide and may le...
AbstractWe have characterized viral–cell interactions of hepatitis C virus (HCV) and liver cells to ...
<p>(A) HCV NS5A inhibits PARP cleavage in HepG2 cells. Western blot analysis shows the expression of...
Background: We previously reported that the hepatitis C virus (HCV) nonstructural protein 5A (NS5A) ...
<p>(A), (B) HCV NS5A enhances GRP78 expression in HepG2 cells. Western blot analysis shows the expre...
To analyze the influence of hepatitis C virus nonstructural protein 5A (NS5A) on apoptosis, we estab...
<p>(A) Amino acid sequences of the HCV NS5A ISDRs of pCXN2-NS5A in the present study. W, wild type; ...
Hepatitis C virus (HCV) infection is one of the major causes of cirrhosis and hepatocellular carcino...
Hepatitis C virus (HCV) infection is one of the major causes of cirrhosis and hepatocellular carcino...
The hepatitis C virus (HCV) causes chronic liver disease leading to fibrosis, cirrhosis, and hepatoc...
The hepatitis C virus (HCV) causes chronic liver disease leading to fibrosis, cirrhosis, and hepatoc...
Background. Hepatitis C virus (HCV) nonstructural protein 5A (NS5A) has been shown to modulate multi...
Background. Hepatitis C virus (HCV) nonstructural protein 5A (NS5A) has been shown to modulate multi...
<p>HepG2-NS5A (<i>A</i>) and HepG2 control (<i>B</i>) cells were treated with 0–10 μM MG132 for 48 h...
AbstractThe mechanisms of hepatocyte death and the events that lead to a high rate of chronic liver ...
AbstractHepatitis C virus (HCV) is a major etiologic agent of chronic hepatitis worldwide and may le...
AbstractWe have characterized viral–cell interactions of hepatitis C virus (HCV) and liver cells to ...
<p>(A) HCV NS5A inhibits PARP cleavage in HepG2 cells. Western blot analysis shows the expression of...
Background: We previously reported that the hepatitis C virus (HCV) nonstructural protein 5A (NS5A) ...
<p>(A), (B) HCV NS5A enhances GRP78 expression in HepG2 cells. Western blot analysis shows the expre...
To analyze the influence of hepatitis C virus nonstructural protein 5A (NS5A) on apoptosis, we estab...
<p>(A) Amino acid sequences of the HCV NS5A ISDRs of pCXN2-NS5A in the present study. W, wild type; ...
Hepatitis C virus (HCV) infection is one of the major causes of cirrhosis and hepatocellular carcino...
Hepatitis C virus (HCV) infection is one of the major causes of cirrhosis and hepatocellular carcino...
The hepatitis C virus (HCV) causes chronic liver disease leading to fibrosis, cirrhosis, and hepatoc...
The hepatitis C virus (HCV) causes chronic liver disease leading to fibrosis, cirrhosis, and hepatoc...
Background. Hepatitis C virus (HCV) nonstructural protein 5A (NS5A) has been shown to modulate multi...
Background. Hepatitis C virus (HCV) nonstructural protein 5A (NS5A) has been shown to modulate multi...
<p>HepG2-NS5A (<i>A</i>) and HepG2 control (<i>B</i>) cells were treated with 0–10 μM MG132 for 48 h...
AbstractThe mechanisms of hepatocyte death and the events that lead to a high rate of chronic liver ...
AbstractHepatitis C virus (HCV) is a major etiologic agent of chronic hepatitis worldwide and may le...
AbstractWe have characterized viral–cell interactions of hepatitis C virus (HCV) and liver cells to ...